SCM
RCEL icon

Segantii Capital Management’s Avita Medical RCEL Stock Holding History

Segantii Capital Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-30,000
Closed -$438K – 170
2023
Q3 		$438K Hold
30,000
– – 0.02% 123
2023
Q2 		$510K Buy
+30,000
New +$440K 0.03% 124

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Segantii Capital Management's RCEL Position: Q4 2023 in Review

Segantii Capital Management sold out of Avita Medical (RCEL) in Q4 2023, closing a stake of 30,000 shares — an estimated $438K sold.

Segantii Capital Management first reported a position in RCEL in Q2 2023 and held it in 2 quarters. The position peaked at $510K in Q2 2023. 84 funds tracked by Wall St. Rank hold RCEL as of Q4 2023.

  • Segantii Capital Management reported no remaining Avita Medical position as of Q4 2023 after selling out during the quarter.
  • Segantii Capital Management sold 30,000 Avita Medical shares in Q4 2023, an estimated $438K.
  • Segantii Capital Management first reported a position in Avita Medical in Q2 2023 and held it in 2 quarters.
  • Segantii Capital Management's Avita Medical position peaked at $510K in Q2 2023.
  • 84 funds tracked by Wall St. Rank held Avita Medical as of Q4 2023.

Based on Segantii Capital Management's 13F filing for Q4 2023, filed 7 Feb 2024.